Boston, MA – According to filings with the U.S. Securities and Exchange Commission, Crio/Clinical Research IO is raising $9,000,000.00 in new funding. Sources indicate as part of senior management President, Raymond Nomizu played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Crio/Clinical Research IO
Clinical Research IO (CRIO) revolutionizes trial studies. We offer powerfully integrated eSource, eRegulatory, CTMS, and stipend solutionsbuilt for sites, by a site owner. At CRIO, company culture is a top priority. Were a Great Place to Work-Certified company and we couldn’t be prouder of our team! Our software frees you from inefficient, error-prone binders to capture source data. CRIOs autofill and data validation tools reduce protocol deviations and save time. With patient scheduling, recruiting, and financial management, we provide you with an all-in-one enterprise solution. Our mission is to help you grow your business. We do that by streamlining your sites operations, so your studies don’t stop just because you aren’t in clinic. CRIO keeps your source data secure, so that you can access it anytime, anywhere.

To learn more about Crio/Clinical Research IO, visit http://www.clinicalresearch.io/

Contact:
Raymond Nomizu, President
617-302-9845
raymond@clinicalresearch.io
https://www.linkedin.com/in/raymond-n-8a895110/

SOURCE: http://www.intelligence360.io
Copyright (c) 2021 SI360 Inc. All rights reserved